Pharma Journalist -

Amgen and UCB announced that the U.S. Food and Drug Administration (FDA) has approved EVENITY (romosozumab-aqqg) for the treatment of osteoporosis in postmenopausal women at high risk…
Read More...

Concerto HealthAI announced that they have entered into a collaboration with Pfizer to advance work in Precision Oncology using Concerto HealthAI’s eurekaHealthTM platform, artificial…
Read More...

Examining the evolving technological and commercial landscape to enhance your precision medicine development Come join us in September 2019 and; thoroughly understand the latest…
Read More...

SMi reports: Metys Pharmaceuticals, Ensysce Biosciences & AstraZeneca will be speaking and presenting at the 19th Annual Pain Therapeutics conference in London, this May. Pain…
Read More...

Eurofins Discovery announced its premier offering for integrated drug discovery services. Eurofins Discovery has successfully collaborated with clients in integrated drug discovery…
Read More...

Sun Pharmaceutical Industries Ltd. announced that INFUGEM™ (gemcitabine in sodium chloride injection), for intravenous use, is now commercially available in the U.S. INFUGEM, the first…
Read More...

Ascentage Pharma, a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, hepatitis B and age-related diseases, announced that it has…
Read More...

Centene Corporation and Washington University School of Medicine in St. Louis announced a partnership to transform and accelerate research into treatments for Alzheimer's disease,…
Read More...

Regeneron Pharmaceuticals and Alnylam Pharmaceuticals announced a collaboration to discover, develop and commercialize new RNA interference (RNAi) therapeutics for a broad range of…
Read More...

SMi reports: In four weeks’ time, Injectable Drug Delivery 2019 will gather an international audience to include regulatory, device design, packaging and formulation professionals. …
Read More...